Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Understanding alopecia areata's patterns can improve future research and treatments.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Ciclosporin might be a good alternative treatment for certain hearing loss that responds to steroids.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Phosphorus homeopathy treatment led to complete hair regrowth in two Alopecia Areata patients.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

New treatments for hair-pulling disorder focus on personalized approaches and combining therapies for better results.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.

Cortisone may help hair regrow by altering the local environment, with regrowth starting 3-4 weeks after treatment, but its use is not widely recommended.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Targeting colon cancer stem cells might lead to better treatment results.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Clobetasol propionate ointment can help some people with total hair loss regrow hair.

Melasma is now considered a skin aging disorder caused by sun exposure in people with a genetic tendency, which impacts treatment and prevention approaches.

Finasteride for hair loss may cause depression, affecting sleep and relationships.

Patients with this syndrome can have different responses and worsening resistance to treatment over time.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.

Group behavior therapy reduces hair-pulling symptoms more than supportive therapy but has limited long-term effectiveness.

Twice-weekly 5 mg dexamethasone can effectively treat extensive alopecia areata in many patients.

Antidepressants may improve or resolve scalp dysesthesia in most patients.